Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With Asthma

Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma

NCT02054130 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma

NCT01448954 ·Status: COMPLETED ·Phase: PHASE2

Phase II Study to Evaluate the Efficacy of AMG 317

NCT00436670 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma

NCT06637371 ·Status: RECRUITING ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma

NCT02512900 ·Status: COMPLETED ·Phase: PHASE1

Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic Asthma

NCT01405963 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of 2-Week Treatment With Inhaled AZD7594 in Adolescents (12 to 17 Years) With Asthma

NCT03976869 ·Status: COMPLETED ·Phase: PHASE1

A Study of 2 Doses of MAP0010 and Placebo in Asthmatic Children

NCT00569192 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma

NCT00046748 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma

NCT01501942 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic Patients

NCT00402948 ·Status: TERMINATED ·Phase: PHASE2

Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma

NCT02243189 ·Status: TERMINATED ·Phase: PHASE1

Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED)

NCT00442351 ·Status: TERMINATED ·Phase: PHASE4

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma

NCT01370317 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma

NCT01793298 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Study of Efficacy and Safety of Brodalumab Compared With Placebo in Adults With Inadequately Controlled Asthma With High Bronchodilator Reversibility

NCT01902290 ·Status: TERMINATED ·Phase: PHASE2

Preventing Asthma in High Risk Kids

NCT02570984 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

TC-6987 for the Treatment of Mild to Moderate Asthma

NCT01296087 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults With Asthma on Medium-to-High Dose Inhaled Corticosteroids

NCT04643158 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma

NCT04987944 ·Status: TERMINATED ·Phase: PHASE1

Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma

NCT05935332 ·Status: TERMINATED ·Phase: PHASE2

Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

NCT02980133 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma

NCT01257230 ·Status: COMPLETED ·Phase: PHASE3

A Randomized Trial Examining the Effectiveness of Mobile-Based Asthma Action Plans vs. Paper Asthma Action Plans

NCT02091869 ·Status: COMPLETED ·Phase: NA

An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma

NCT02219048 ·Status: TERMINATED ·Phase: PHASE2